GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 81 filers reported holding GLYCOMIMETICS INC in Q2 2019. The put-call ratio across all filers is 145.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $277,000 | -63.8% | 64,200 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $765,000 | -2.4% | 64,200 | +2.1% | 0.00% | 0.0% |
Q1 2019 | $784,000 | +35.9% | 62,900 | +3.3% | 0.00% | 0.0% |
Q4 2018 | $577,000 | -32.3% | 60,900 | +2.9% | 0.00% | 0.0% |
Q3 2018 | $852,000 | -10.8% | 59,200 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $955,000 | – | 59,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,361,801 | $38,944,000 | 2.95% |
NEA Management Company, LLC | 9,089,041 | $48,081,000 | 2.27% |
Camber Capital Management LP | 3,500,000 | $18,515,000 | 0.94% |
Redmile Group, LLC | 1,343,845 | $7,109,000 | 0.17% |
CAXTON CORP | 25,748 | $136,000 | 0.13% |
Alambic Investment Management, L.P. | 15,210 | $80,000 | 0.07% |
Virtus ETF Advisers LLC | 69,120 | $366,000 | 0.06% |
OXFORD ASSET MANAGEMENT LLP | 133,008 | $704,000 | 0.02% |
AXA S.A. | 1,890,492 | $10,002,000 | 0.02% |
Athanor Capital, LP | 59,572 | $315,000 | 0.01% |